US Stock MarketDetailed Quotes
ADGM Adagio Medical
- 5.800
- +0.375+6.91%
Close Aug 9 16:00 ET
- 5.800
- 0.0000.00%
Post 20:01 ET
73.67MMarket Cap-22307P/E (TTM)
6.230High4.910Low23.77KVolume5.260Open5.425Pre Close126.29KTurnover0.55%Turnover RatioLossP/E (Static)12.70MShares11.57052wk High0.80P/B25.11MFloat Cap4.00052wk Low--Dividend TTM4.33MShs Float12.380Historical High--Div YieldTTM24.33%Amplitude4.000Historical Low5.312Avg Price1Lot Size
About Adagio Medical Company
Adagio Medical Holdings, Inc. is a medical device company, which engages in the development and placing on the EU market of innovative ablation technologies for the treatment of cardiac arrhythmias. It treats atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded on August 24, 2020 and is headquartered in New York, NY.
Company Profile
SymbolADGM
Company NameAdagio Medical
Listing DateFeb 26, 2021
Founded2020
CEOMr. Adam Stone
MarketNASDAQ
Employees3
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address51 Astor Place,10th Floor
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10003
Phone1-212-284-2300
Company Executives
- Name
- Position
- Salary
- Adam Stone
- Chief Executive Officer and Director
- --
- Michael Altman, C.F.A.
- Chief Financial Officer, Principal Accounting Officer and Director
- --
- Konstantin Poukalov
- Chief Business Officer
- --
- Joseph Edelman
- Chairman of the Board
- --
- Dr. Michael Henderson, M.D.
- Independent Director
- --
- Leslie L. Trigg
- Independent Director
- --
- Dr. Todd Wider, M.D.
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg